Modulation of PAI-1 and tPA Activity and Thrombolytic Effects of Corilagin

Planta Medica

Volumn 69, Issue 12, 2003, Pages 1109-1112

  Shen, Zhi Qiang ^a,b   Dong, Ze Jun ^a   Peng, Hua ^a   Liu, Ji Kai ^a  

^a KUNMING INSTITUTE OF BOTANY   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Corilagin; Euphorbiaceae; Phyllanthus urinaria; Thrombolysis; Tissue type plasminogen activator; Type 1 plasminogen activator inhibitor

Indexed keywords

CHROMOGENIC SUBSTRATE; CORILAGIN; FIBRINOLYTIC AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; BLOOD CLOT LYSIS; BLOOD VESSEL OCCLUSION; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CHINESE HERB; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; MALE; MODULATION; NONHUMAN; PHYLLANTHUS; PHYLLANTHUS URINARIA; PLASMA; RABBIT; RAT; RECURRENT DISEASE; REPERFUSION; TECHNIQUE; THROMBOCYTE AGGREGATION; THROMBOCYTE RELEASE REACTION; VASCULAR PATENCY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSIDES; MALE; PHYLLANTHUS; PHYTOTHERAPY; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

ANIMALIA; EUPHORBIACEAE; ORYCTOLAGUS CUNICULUS; PHYLLANTHUS URINARIA;

EID: 1242351802     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-45191     Document Type: Article

References (18)

1. Hoylaerts M, Rijken DC, Lijnen HR, Collen D. Kinetics of the activation of plasminogen by human tissue plasminogen activator: role of fibrin. J Biol Chem 1982; 257: 2912-9
2. Tomihisa K, Masao K, Seiji K, Hiroshi G, Toichi T, Yoshiki Y, Chuichi K. Thrombolytic activity of a novel modified tissue-type plasminogen activator, YM866, in a canine model of coronary artery thrombosis. Jpn J Pharmacol 1993; 63: 9-16
3. Sancho E, Declerk PJ, Price NC, Kelly SM, Booth NA. Conformational studies on plasminogen activator inhibitor (PAI-1) in active, latent, substrate and cleaved forms. Biochemistry 1995; 34: 1064-9
4. Torr-Brown SR, Sobel BE. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets. Thromb Res 1993; 72: 413-21
5. An XG, Han ZC, Wang PX, Wu HZ, Zhou LL. Study on the relationship between plasminogen activator inhibitor-1 levels and acute myocardial infarction. Chinese J Cardiovasol 2001; 6: 71-4
6. Thogersen AM, Jansson JH, Boman K. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 1998; 98: 2241-7
7. Dictionary of Chinese Traditional Medicine. Shanghai: 1977: pp. 1496-7
8. Cheng JT, Lin TC, Hsu FL. Antihypertensive effect of corilagin in the rat. Can J Physiol Pharmacol 1995; 73: 1425-9
9. Satomi H, Umemura K, Ueno A, Hatano T, Okuda T, Noro T. Carbonic anhydrase inhibitors from the pericarps of Punica granatum L. Biol Pharm Bull 1993; 16: 787-90
10. Xu HX, Wan M, Dong H, But PP, Foo LY. Inhibitory activity of flavonoids and tannins against HIV-1 protease. Biol Pharm Bull 2000; 23: 1072-6
11. Liu JK, Huang Y, Henkel T, Weber K. One step purification of corilagin and ellagic acid from Phyllanthus urinaria using high-speed counter-current chromatography. Phytochem Analysis 2002; 13: 1-3
12. Yoshida T, Itoh H, Matsunaga S, Tanaka R, Okuda T. Tannins and related polyphenols of Euphorbiaceous plants. Chem Pharm Bull 1992; 40: 53-60
13. Charlton PA, Faint RW, Bent F, Bryans J, Chicarelli-Robinson I, Mackie I, Machin S, Bevan P. Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activity. Thromb Haemostasis 1996; 75: 808-15
14. Tomihisa K, Masso K, Seiji K, Hiroshi G, Toichi T, Yoshiki Y, Chuichi K. Thrombolysis with intracoronary administration of YM866, a novel modified tissue-type plasminogen activator, in a canine model of coronary artery thrombosis. Jpn J Pharmacol 1993; 63: 319-25
15. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-9
16. Biemond BJ, Levi M, Coronel R, Janse MJ, ten Cate JW, Pannekoek H. Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis - effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibody. Circulation 1995; 91: 1175-81
17. Fay WP, Shapiro AD, Shih JL, Schleef RR, Ginsburg D. Complete deficiency of plasminogen activator inhibitor type-1 due to a frame-shift mutation. New Engl J Med 1992; 327: 1729-33
18. Liu JK, Henkel T. Traditional Chinese Medicine (TCM): Are polyphenols and saponins the key ingredients triggering biological activities? Curr Med Chem 2002; 9: 1483-5